FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Ilhan Omar’s turbulent week explained: The dueling probes that threw the Somali-born progressive into chaos

Income inequality at Obama Foundation, as brass thrives and rank and file seeks union

Pentagon Sends 600 Soldiers Into Latin America as Trump Turns Up Heat on Cartels

Noem reassignment caps tumultuous week of terminations and reshuffling at State Department

Josh Shapiro moves into the starting blocks for 2028 with new PAC

Russia ‘exploiting’ midterm elections to position US against Ukraine: ‘We fully agree with President Trump’

Ilhan Omar raid sparks ominous prediction from watchdog: ‘They probably got the goods’

Army expo attendees skeptical of Trump’s Iran peace deal hopes: ‘Beat ’em into submission’

Chinese National Arrested at US University for Poisoning Classmate Engaged in Cutting Edge Cancer Research

Dems Make Historic All-In Midterm Move: Talarico Raises More in Third Quarter Than Any Senate Candidate in History

Politicians Force Their Hands Into Taxpayer Pockets to Fund Agency That Bombed Audit

Fox News Campus Radicals Newsletter: Judeo-Christian values under assault in American schools

State Treasurers Stand Up to the Big 3 Rating Agencies for Punishing Oil-Friendly States with Green-Activist ESG

Breaking: Homes Destroyed, 70k Without Power as Wildfires Devastate Southern California

Cookies, liquor and mocking Nazis fuel final stretch in fiery Texas House race

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”